156. Back to Basics - Prostate Cancer - Biochemical Recurrence and Oligometastatic Disease Control cover art

156. Back to Basics - Prostate Cancer - Biochemical Recurrence and Oligometastatic Disease Control

156. Back to Basics - Prostate Cancer - Biochemical Recurrence and Oligometastatic Disease Control

Listen for free

View show details

About this listen

As we "EMBARK" on our next Prostate Cancer adventure via the "SOLAR" system to "SATURN," Michael and Josh explore the idea of biochemical recurrence in prostate cancer and the role of radiotherapy in tumour-directed therapy for de novo versus recurrent PSMA PET–defined oligo-M1 prostate cancer. Both excellent studies raise the question of newer technologies and how we apply this information to trials that already exist.


Studies discussed in the episode:

EMBARK

SOLAR/SATURN


For more episodes, resources and blog posts, visit www.inquisitiveonc.com

Please find us on Twitter @InquisitiveOnc!

If you want us to look at a specific trial or subject, email us at inquisitiveonc@gmail.com


Art courtesy of Taryn Silver

Music courtesy of AlisiaBeats: https://pixabay.com/users/alisiabeats-39461785/


Disclaimer: This podcast is for educational purposes only. If you are unwell, seek medical advice.


Oncology for the Inquisitive Mind is recorded with the support of education grants from our foundation partners Pfizer, Gilead Pharmaceuticals and Merck Pharmaceuticals. Our partners have access to the episode at the same time you do and have no editorial control over the content.



Hosted on Acast. See acast.com/privacy for more information.

What listeners say about 156. Back to Basics - Prostate Cancer - Biochemical Recurrence and Oligometastatic Disease Control

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.